CSIMarket


Becton Dickinson And Company  (BDX)
Other Ticker:  
 


 

Becton Dickinson And Company

BDX's Financial Statements and Analysis



Becton Dickinson And Company reported in IV. Quarter net earnings per share of $0.92 an increase by 10.17 % year on year from $0.84 and decline of -22 % from $1.18 earned in III. Quarter (Jun 30 2022).


IV. Quarter
Earnings Per Share Revenues
$ 0.92 $  4,223 Mill
$+0.08     +10.17 % $-913M     -17.78 %



Becton Dickinson's Revenue fell by -17.78 % in IV. Quarter (Sep 30 2022) year on year, to $4,223 million and declined by -9.01 % sequentially.


Becton Dickinson is Expected to report next financial results on February 02, 2023.

More on BDX's Income Statement





       
  • Medical Surgical Systems 137.63% Y/Y,
• Medical Total 64.86% Y/Y,
• Diagnostics Total 35.64% Y/Y
   
     
       
  • Diabetes Care -5.04% Y/Y,
• Pharmaceutical Systems -5.67% Y/Y,
• Preanalytical Systems -4.12% Y/Y,
• Diagnostic Systems -4.13% Y/Y,
• Immunocytometry Systems -2.89% Y/Y
   
     


BDX's Segments

Becton Dickinson's net income of $286.000 million in IV. Quarter increased by 8.75 % from net earnings of $263.000 million achieved in IV. Quarter a year ago.

Sequentially net earnings fell by -20.78 % from net income of $361.000 million realized in previous quarter.

More on BDX's Growth



Becton Dickinson Income Growth by Division
• Medical Total 35.67% Y/Y • Biosciences Total -28.88% Y/Y Inventories grew by 12.49 % to $3,224 million from IV. Quarter a year ago, sequentially inventories rose by 1.93 %. In IV. Quarter company's net cash and cash equivalents decreased by $-1,601 million, capital expenditures grew by -32.26%, to $-315 millions compare to same quarter a year ago and fell by 29.63% from III. Quarter (Jun 30 2022).

More on BDX's Cash flow Statement


Becton Dickinson And Company payed out dividend of $3.55 per share in last 52 weeks representing 60.37 % of net earning per share in trailing twelve-month period.

During the same period Becton Dickinson And Company earned $ 8.60 cash per share, on a free-cash flow basis 146.3 % of net earning per share.